BCR genes, SHM can be studied using other platforms that provide longer read lengths, albeit with less depth per sequencing run ( Figure 2 ). 2, 9 Both genomic DNA and cDNA from lymphocytes have been used as the template for sequencing, but genomic DNA is preferred for studies in which the relative frequency of specific BCR or TCR sequences is to be assessed. Molecular and computational strategies based on high-throughput DNA sequencing have made it possible to explore BCR and TCR sequence repertoires of any degree of complexity, and thereby to address biological questions that were never before amenable to direct experimental analysis.
Defining the characteristics of B-and T-cell repertoires
High-throughput sequencing of rearranged BCR and TCR genes in lymphocytes from peripheral blood has begun to define the essential characteristics of the B-and T-cell repertoires in healthy adults. Sequencing of the IGH locus in naïve B cells from 4
individuals revealed an average of ~86,000 unique CDR3 sequences per person. 4 Up to 10 Statistical methods developed for estimating total species diversity in ecological and microbial communities 11, 12 have been used to estimate total CDR3 sequence diversity, including the sequences that are directly observed as well as those that remain "unseen" due to the fact that such diverse repertoires cannot be sampled completely. Such efforts have suggested that the naïve and memory CD8 + and CD4 + TCR β chain CDR3 repertoires in healthy adults collectively contain at least 3-4 x 10 6 unique sequences, 6 with at least as many unique TCR α chain CDR3 sequences. 8 The IGH CDR3 repertoire is estimated to contain at least 10 6 distinct sequences. 2 The IGH and TCRβ repertoires are both characterized by an extremely large number of CDR3 sequences that are present at low frequencies. 2, [5] [6] [7] It has therefore proven difficult, despite the application of methods for estimating unseen species diversity, to determine the true diversity in individual BCR and TCR repertoires with great accuracy, and the published estimates are best viewed as lower bounds for repertoire diversity.
Although most of the deep sequencing studies published to date have focused on the TCRβ and IGH loci, the loci that encode the α chains of αβ T cells and the γ chains of γδ T cells have also been explored. Analysis of TCRα CDR3 sequences in several subsets of αβ T cells from a single individual revealed 1.2 to 2.4-fold more unique TCRα than TCRβ CDR3 sequences in each the subsets studied. 8 Sequencing of the TCRγ locus has provided valuable insight into the structure of the γδ T-cell repertoire. Although the theoretical diversity of γδ TCRs rivals that of αβ TCRs, the antigen receptors expressed by peripheral blood γδ T cells demonstrate very limited TCR CDR3 sequence diversity.
For personal use only. on . by guest www.bloodjournal.org From Indeed, deep sequencing of the rearranged TCRγ genes expressed in peripheral blood γδ T cells from 3 healthy adults revealed that 45% of the TCRγ CDR3 sequences from the 3 individuals were identical to a previously described sequence found in a "public" γδ TCR, found in most individuals, that is specifically reactive with non-peptide prenyl pyrophosphate antigens. 13 Deep sequencing of the TCRγ locus in αβ and γδ T cells from peripheral blood of healthy adults has also provided valuable insight into the process by which T cells are committed to the αβ or γδ lineages during thymic development. The vast majority of both αβ and γδ T cells in peripheral blood contain rearranged TCRγ genes, suggesting that rearrangement of the TCRγ locus occurs before αβ/γδ lineage commitment. [14] [15] [16] In contrast, only a very small fraction (<4%) of γδ T cells appear to have rearranged TCRβ loci, suggesting that rearrangement of the TCRβ locus only occurs in T cells that have committed to the αβ lineage. 16 Comparison of the TCR repertoires carried in specific T cell subsets within single individuals is the focus of several current studies, and has great potential for defining the relationships between subsets as well as illuminating the developmental pathways that lead to each subset. reads/sample in 6 CLL patients after allogeneic HCT revealed that reconstitution of IGH diversity to levels observed in the HCT donor typically required more than 1 year.
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Although repertoire diversity was a primary end point in all 3 of these studies, they did not address the important issues of sampling depth, the existence of "unseen" CDR3 sequence diversity, or possible confounding by inter-sample variation in absolute T or B lymphocyte count. Nonetheless, these 3 pilot studies have provided valuable initial data on the reconstitution of lymphocyte repertoire diversity after allogeneic HCT, and have laid the foundation for more comprehensive future studies. 
Limitations of antigen receptor sequencing
Current strategies for analysis of BCR and TCR repertoires using high-throughput sequencing have notable limitations. All protocols use multiplex PCR to amplify the rearranged variable regions of antigen receptor loci to provide sufficient template DNA for sequencing, which introduces bias due to more efficient amplification of some templates compared with others. 6 Such bias can be addressed molecularly and computationally if its magnitude can be accurately determined. Analysis and interpretation of antigen receptor sequence data also poses a number of lingering computational challenges, one of the most difficult of which is inferring the most likely sequence of molecular events that produced each antigen receptor sequence. Addressing these challenges has provided the rationale for the nascent field of computational immunology.
Conclusions and future research directions
Application of high-throughput sequencing to the analysis of B-and T-cell antigen receptor repertoires is elucidating the fundamental structure of lymphocyte repertoires and seems poised to transform the diagnosis and monitoring of B-and T-lymphoid malignancies. The scientific and clinical utility of this innovative technology will strongly depend on the accuracy, precision, and reproducibility with which it can define both the number of unique antigen receptor sequences in a given clinical specimen and their relative frequency. Future studies that aim to compare the relative frequency of specific BCR or For personal use only. on . by guest www.bloodjournal.org From
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